Nanocrystals as a promising approach for enhancing solubility and dissolution of etoricoxib using Box–Behnken design
Abstract Poor solubility of drugs represents a major obstacle against drug delivery, so pharmaceutical industry is exploring the use of nanocrystals as a promising approach to enhance the bioavailability of those medications with improving their pharmacokinetics. This study aims to improve etoricoxi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-12837-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849763644551725056 |
|---|---|
| author | Lamiaa M. Ahmed Fergany A. Mohamed Tahani H. Elfaham |
| author_facet | Lamiaa M. Ahmed Fergany A. Mohamed Tahani H. Elfaham |
| author_sort | Lamiaa M. Ahmed |
| collection | DOAJ |
| description | Abstract Poor solubility of drugs represents a major obstacle against drug delivery, so pharmaceutical industry is exploring the use of nanocrystals as a promising approach to enhance the bioavailability of those medications with improving their pharmacokinetics. This study aims to improve etoricoxib properties via nanocrystal form using an acid-base precipitation method. This method is simple, environment- friendly, and prefers non-organic solvents and chemicals, thus overcoming challenges in developing dosage forms. Prepared nanocrystals were optimized for several factors such as stabilizer type and concentration, amount of drug, time and speed of homogenization. FT-IR, DSC, X-ray diffraction, and TEM characterizations were conducted on the optimized nanocrystal formula. The findings showed a successful inclusion of etoricoxib as nanocrystals with a mean particle size of 210.30 ± 10.20 nm, PDI of 0.277 ± 0.01, and a zeta potential of − 74.10 ± 0.61 mV. TEM imaging revealed well-defined cubic-shaped nanoparticles, indicating morphological uniformity and excipient compatibility. Solubility studies demonstrated notable enhancement in the aqueous solubility of etoricoxib nanocrystals (137.75 ± 1.34 µg/mL) compared to the pure drug (87.70 ± 1.41 µg/mL). Additionally, the nanocrystals exhibited rapid dissolution profile, achieving 91.49 ± 0.01% drug release within 5 min. These results suggest that using nanocrystals to improve the aqueous solubility and dissolution of medications with poor solubility is a potential strategy. |
| format | Article |
| id | doaj-art-2ae198ba3f1444c19e90bc0da311be88 |
| institution | DOAJ |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-2ae198ba3f1444c19e90bc0da311be882025-08-20T03:05:21ZengNature PortfolioScientific Reports2045-23222025-08-0115111510.1038/s41598-025-12837-3Nanocrystals as a promising approach for enhancing solubility and dissolution of etoricoxib using Box–Behnken designLamiaa M. Ahmed0Fergany A. Mohamed1Tahani H. Elfaham2Department of pharmaceutics, Faculty of pharmacy, Assiut UniversityDepartment of pharmaceutics, Faculty of pharmacy, Assiut UniversityDepartment of pharmaceutics, Faculty of pharmacy, Assiut UniversityAbstract Poor solubility of drugs represents a major obstacle against drug delivery, so pharmaceutical industry is exploring the use of nanocrystals as a promising approach to enhance the bioavailability of those medications with improving their pharmacokinetics. This study aims to improve etoricoxib properties via nanocrystal form using an acid-base precipitation method. This method is simple, environment- friendly, and prefers non-organic solvents and chemicals, thus overcoming challenges in developing dosage forms. Prepared nanocrystals were optimized for several factors such as stabilizer type and concentration, amount of drug, time and speed of homogenization. FT-IR, DSC, X-ray diffraction, and TEM characterizations were conducted on the optimized nanocrystal formula. The findings showed a successful inclusion of etoricoxib as nanocrystals with a mean particle size of 210.30 ± 10.20 nm, PDI of 0.277 ± 0.01, and a zeta potential of − 74.10 ± 0.61 mV. TEM imaging revealed well-defined cubic-shaped nanoparticles, indicating morphological uniformity and excipient compatibility. Solubility studies demonstrated notable enhancement in the aqueous solubility of etoricoxib nanocrystals (137.75 ± 1.34 µg/mL) compared to the pure drug (87.70 ± 1.41 µg/mL). Additionally, the nanocrystals exhibited rapid dissolution profile, achieving 91.49 ± 0.01% drug release within 5 min. These results suggest that using nanocrystals to improve the aqueous solubility and dissolution of medications with poor solubility is a potential strategy.https://doi.org/10.1038/s41598-025-12837-3EtoricoxibNanocrystalsBox–BehnkenSaturation solubilityDissolution |
| spellingShingle | Lamiaa M. Ahmed Fergany A. Mohamed Tahani H. Elfaham Nanocrystals as a promising approach for enhancing solubility and dissolution of etoricoxib using Box–Behnken design Scientific Reports Etoricoxib Nanocrystals Box–Behnken Saturation solubility Dissolution |
| title | Nanocrystals as a promising approach for enhancing solubility and dissolution of etoricoxib using Box–Behnken design |
| title_full | Nanocrystals as a promising approach for enhancing solubility and dissolution of etoricoxib using Box–Behnken design |
| title_fullStr | Nanocrystals as a promising approach for enhancing solubility and dissolution of etoricoxib using Box–Behnken design |
| title_full_unstemmed | Nanocrystals as a promising approach for enhancing solubility and dissolution of etoricoxib using Box–Behnken design |
| title_short | Nanocrystals as a promising approach for enhancing solubility and dissolution of etoricoxib using Box–Behnken design |
| title_sort | nanocrystals as a promising approach for enhancing solubility and dissolution of etoricoxib using box behnken design |
| topic | Etoricoxib Nanocrystals Box–Behnken Saturation solubility Dissolution |
| url | https://doi.org/10.1038/s41598-025-12837-3 |
| work_keys_str_mv | AT lamiaamahmed nanocrystalsasapromisingapproachforenhancingsolubilityanddissolutionofetoricoxibusingboxbehnkendesign AT ferganyamohamed nanocrystalsasapromisingapproachforenhancingsolubilityanddissolutionofetoricoxibusingboxbehnkendesign AT tahanihelfaham nanocrystalsasapromisingapproachforenhancingsolubilityanddissolutionofetoricoxibusingboxbehnkendesign |